Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00989651
Title Carboplatin, Paclitaxel, Bevacizumab, and ABT-888 in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

fallopian tube carcinoma

ovarian carcinosarcoma

peritoneal carcinoma

fallopian tube carcinosarcoma

ovarian carcinoma

Therapies

Bevacizumab + Veliparib

Carboplatin

Paclitaxel

Cisplatin

Age Groups: adult
Covered Countries USA


No variant requirements are available.